| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, Global Head Of R&D | Global Head Of R&D
1 company
Wang Lai is a President, Global Head Of R&D at BeOne Medicines Ltd.. Recent SEC Form 4 filings include 0 buys and 27 sells.
Estimated insider holdings value: $460.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2025 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 5,000 | $350.06 | $1,750,311.50 | -100% | -7.0% | - | |
| Jul 30, 2025 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 4,300 | $302.65 | $1,301,375.41 | -61.7% | +5.6% | - | |
| Jul 18, 2025 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 700 | $300.00 | $210,000.00 | -100% | +8.0% | - | |
| Jun 23, 2025 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 1,028 | $260.00 | $267,280.00 | -100% | +31.2% | - | |
| Jun 17, 2025 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 1,647 | $262.11 | $431,699.06 | -77.8% | +30.8% | - | |
| Jun 6, 2025 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 1,402 | $252.39 | $353,853.30 | -45.2% | +24.6% | - | |
| Feb 21, 2025 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 5,000 | $257.23 | $1,286,174.03 | -29.5% | -6.5% | +41.8% | |
| Sep 27, 2024 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 5,000 | $220.35 | $1,101,774.00 | -100% | -15.4% | +49.3% | |
| Jun 24, 2024 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 1,064 | $159.80 | $170,029.80 | -99.8% | +26.5% | +67.6% | |
| Jun 18, 2024 | ONC Beone Medicines Ltd. | Global Head Of R&D | Sell | 2,341 | $157.27 | $368,161.66 | -29.1% | +27.0% | +63.4% |